The case against "just lose weight" — metabolic health at its roots.

"Just lose weight" is not a plan. It is a description of a hoped-for outcome, delivered as though it were an instruction, usually to someone who has already tried.

It also gets the causation backwards more often than is generally acknowledged. Weight gain is frequently downstream of metabolic dysfunction rather than the origin of it — which is why advice aimed at the number on the scale so often fails, and why people conclude the failure was theirs.

I want to make the case for starting somewhere else.

The sequence nobody sees

Insulin resistance develops quietly and in a fairly consistent order.

Cells become less responsive to insulin's signal. The pancreas compensates by producing more. That extra insulin succeeds — glucose stays in range, sometimes for a decade or more. During that whole period, a fasting glucose reads normal, because the system is working hard to keep it normal. Glucose rises only when compensation finally fails.

Insulin is also a storage signal. Elevated insulin promotes fat storage and inhibits its release. So the same process that keeps glucose looking fine is simultaneously making weight harder to shift — and the person is then told the weight is the problem.

By the time fasting glucose is abnormal, the process has usually been running for years. Glucose is a late marker of an early problem.

What to measure instead

Fasting insulin is the one most likely to change how someone understands their situation, and it is not on standard panels. Paired with fasting glucose it produces HOMA-IR, an index of insulin resistance that moves years before glucose does.

The triglyceride-to-HDL ratio can be calculated from a lipid panel most people already have. It correlates reasonably with insulin resistance in many populations and costs nothing to work out.

HbA1c gives a roughly three-month average of glucose exposure — useful, with the caveat that it reflects red cell lifespan and can mislead in anaemia or altered cell turnover.

hsCRP captures low-grade inflammation, which travels with metabolic dysfunction in both directions.

And because visceral fat is the metabolically consequential kind, waist measurement tells you more than body weight does. Two people at the same weight can have very different amounts of it.

Liver enzymes belong here too. Fatty liver is common, often silent, and frequently the first structural sign that this process is underway.

Weight is a symptom, and also a confounded one

Body weight is a poor measurement for what we actually care about. It does not distinguish muscle from fat, or visceral fat from subcutaneous. It moves several pounds day to day with fluid and glycogen. And it says nothing about insulin sensitivity, inflammation or lipid particle count — the things that determine cardiovascular and metabolic outcomes.

People can be metabolically unhealthy at a normal weight, and metabolically healthy at a higher one. Neither is universal, but both are common enough that treating weight as the variable of interest misdirects a great deal of effort.

There is a practical consequence. When markers improve — insulin falling, triglycerides dropping, hsCRP settling, liver enzymes normalising — that is real progress whether or not the scale has moved much. Someone measuring only weight will miss it, and may abandon something that was working.

Where a protocol actually starts

Not with a diet. With the things that are dragging on the system underneath.

Sleep, because even short periods of restriction measurably reduce insulin sensitivity in healthy people. Someone sleeping five hours is fighting their own physiology and will interpret the difficulty as a failure of willpower.

Muscle, because skeletal muscle is where most glucose is disposed of, and resistance training improves insulin sensitivity through pathways that do not depend on insulin at all. This is one of the most reliable interventions available and it is not primarily about weight.

The things that mimic or worsen it — thyroid function, iron status, vitamin D, medications known to affect insulin sensitivity, alcohol intake, and chronic stress load. Each is checkable, and each can quietly account for a good deal of what is being blamed on discipline.

Then nutrition, shaped around what a person can sustain and what their labs indicate, rather than around a named diet. And where it is clinically appropriate, medication — GLP-1 receptor agonists among other options — considered on its merits for that individual rather than as either a shortcut or a moral failing.

A note on how this gets discussed

Metabolic health is a domain where a lot of harm is done by tone.

People arrive having been told, repeatedly, that the answer is to eat less and try harder. Many have cycled through that for decades. Some have arrived at a genuinely disordered relationship with food along the way, and for those patients an intensified focus on restriction, numbers and targets is the opposite of what is needed — it is a place where clinical care has to slow down rather than speed up.

Measuring the underlying biology helps here in a way that goes beyond the data. It reframes the problem as a physiological one with identifiable contributors, which is both more accurate and considerably more useful than a verdict about character.

If you have been told to just lose weight, the more productive question is: lose it how, and against what measurement, and what is making it difficult in the first place? That question has answers. The instruction never did.

This article is educational and is not medical advice, diagnosis, or treatment. Laboratory results and therapies require interpretation in the context of your history, symptoms, medications, and examination, and what is appropriate differs from person to person. Nothing here should be used to start, stop, or change any treatment. Please speak with a qualified clinician who knows your case.